NCT00027937View on ClinicalTrials.gov

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2001

Study Completion Date

November 30, 2007

Conditions
LymphomaUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

filgrastim

BIOLOGICAL

sargramostim

DRUG

busulfan

DRUG

cyclophosphamide

DRUG

melphalan

DRUG

paclitaxel

DRUG

thiotepa

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00027937 - Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter